{"id":"CHEMBL1024","canonicalSmiles":"O=P1(NCCCl)OCCCN1CCCl","inchiKey":"HOMGKSMUEGBAAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IFOSFAMIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ifex","Ifosfamide","Ifsofamide","Mitoxana"],"synonyms":["Ifosfamide","Isophosphamide","MJF 9325","MJF-9325","NSC-109724","Z-4942","Z4942"],"crossReferences":{"DailyMed":["ifosfamide"],"PubChem":["11112546","144204090","144209013","144213092","170464854","174007357","301170","56463644"],"Wikipedia":["Ifosfamide"],"drugbank":["DB01181"],"chEBI":["5864"]},"childChemblIds":["CHEMBL342466"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 5 approved and 68 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL103667","canonicalSmiles":"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1","inchiKey":"MVCOAUNKQVWQHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIRB 796 BS","BIRB-796","BIRB-796 BS","Birb-796","Doramapimod"],"crossReferences":{"PubChem":["103904828","124950164","144206937","170466618","50100090"],"drugbank":["DB03044"],"chEBI":["40953"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1194345","canonicalSmiles":"N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F","inchiKey":"SOSYXEPELJIJHZ-RNCFNFMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1194345","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07021"]},"childChemblIds":["CHEMBL562188","CHEMBL552068"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200413","canonicalSmiles":"Cl.c1ccc2c(c1)CCCC2C1=NCCN1","inchiKey":"BJORNXNYWNIWEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROZOLINE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1266","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tyzine"],"synonyms":["NSC-757339","Tetrahydrozoline hydrochloride","Tetrahydrozoline nitrate","Tetryzoline","Tetryzoline hydrochloride"],"crossReferences":{"PubChem":["170464943","26747671","50107052","56424102","855698"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MP_0001845","EFO_0000678"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 2 investigational indications."}
{"id":"CHEMBL1200760","canonicalSmiles":"O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]","inchiKey":"CKMOQBVBEGCJGW-LLIZZRELSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BALSALAZIDE DISODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201346","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Balsalazide disodium","Colazal","Colazide","Giazo"],"synonyms":["BX-661A","BX661A","Balsalazide disodium","Balsalazide disodium anhydrous","Balsalazide disodium dihydrate","Balsalazide disodium salt dihydrate","Balsalazide sodium","Balsalazine","NSC-760046"],"crossReferences":{"DailyMed":["balsalazide%20disodium"]},"linkedTargets":{"rows":["ENSG00000132170","ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for ulcerative colitis."}
{"id":"CHEMBL1200991","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4c(c3)CCC4)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"QFWPXOXWAUAYAB-XZVIDJSISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN INDANYL SODIUM","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1596","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geocillin"],"synonyms":["CP-15,464-2","CP-15464-2","Carbenicillin indanyl sodium","Carindacillin sodium","Carindacillin sodium salt"],"crossReferences":{"Wikipedia":["Carindacillin"],"chEBI":["31358"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972 and has 1 investigational indication."}
{"id":"CHEMBL1201011","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O.Cl","inchiKey":"IBBLRJGOOANPTQ-JKVLGAQCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINAPRIL HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1592","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accupril","Accupro","Quinapril hydrochloride","Quinil"],"synonyms":["CI 906","CI-906","NSC-758222","Quinapril hcl","Quinapril hydrochloride"],"crossReferences":{"DailyMed":["quinapril%20hydrochloride"],"PubChem":["144204934","144207588","170465312","49648461"],"chEBI":["8714"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000712","EFO_0000400","EFO_1002048","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 5 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201130","canonicalSmiles":"C[N+](C)(C)CC(=O)O.[Cl-]","inchiKey":"HOPSCVCBEOCPJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL95889","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acidol pepsin","Cystadane"],"synonyms":["Betaine HCl","Betaine hcl","Betaine hydrochloride","Betainum muriaticum","Lycine hydrochloride","NSC-32191","NSC-3976"],"crossReferences":{"PubChem":["144204926","144212459","170464844","26748661","50105912","56462965"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201643","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PROMPT PURIFIED PORK","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Semilente"],"synonyms":["Insulin zinc susp prompt purified pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1229093","canonicalSmiles":"COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=C(C)C1=O","inchiKey":"OIIMUKXVVLRCAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOQUINONE CATION","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mitoquinone","Mitoquinone cation","Mitoquinone ion"],"childChemblIds":["CHEMBL4074884","CHEMBL1223781"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1230051","canonicalSmiles":"O=C(Nc1cccc(-c2n[nH]c3ccc(-c4nc[nH]n4)cc23)c1)c1ccco1","inchiKey":"LMDMJDCLPIVGQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230051","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231418","canonicalSmiles":"CC1=C(Br)C(=O)C(C(C)C)=C(Br)C1=O","inchiKey":"GHHZELQYJPWSMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Dibromothymoquinone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04646"],"chEBI":["19371"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231861","canonicalSmiles":"CC(C)(O)C#N","inchiKey":"MWFMGBPGAXYFAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLKETONE CYANOHYDRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208688","144213573"],"drugbank":["DB02203"],"chEBI":["15348"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232328","canonicalSmiles":"CCOP(O)(=S)OCC","inchiKey":"PKUWKAXTAVNIJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O,O-DIETHYL S-HYDROGEN PHOSPHOROTHIOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07674"],"chEBI":["28006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234355","canonicalSmiles":"CC(C)(CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)O","inchiKey":"LTYOQGRJFJAKNA-DVVLENMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALONYL-COENZYME A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04524"],"chEBI":["15531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236122","canonicalSmiles":"COC(=O)c1cc(OC)c(O)c(OC)c1","inchiKey":"ZMXJAEGJWHJMGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SYRINGATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08589"],"chEBI":["45820"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237082","canonicalSmiles":"CNC1(C)C2CCC(C2)C1(C)C.Cl","inchiKey":"PKVZBNCYEICAQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECAMYLAMINE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL267936","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inversine","Mecamylamine hydrochloride"],"synonyms":["Mecamylamine chloride","Mecamylamine hcl","Mecamylamine hydrochloride","NSC-757086"],"crossReferences":{"DailyMed":["mecamylamine%20hydrochloride"],"PubChem":["50106687","50106688","50106689"]},"linkedTargets":{"rows":["ENSG00000080644","ENSG00000117971"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and has 1 investigational indication."}
{"id":"CHEMBL127214","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(-c2ccsc2)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(-c2ccsc2)cc1)C(=O)N[C@H](C(=O)NC)C(C)C)C(C)C","inchiKey":"AJZAPEZJWWQJHC-UWNKZCSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL127214","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04547"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL143305","canonicalSmiles":"Cc1cc(CCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1","inchiKey":"TUGBWRGTMLOFAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL143305","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08728"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1471","canonicalSmiles":"C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"ATALOFNDEOCMKK-OITMNORJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APREPITANT","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aprepitant","Cinvanti","Emend"],"synonyms":["Aprepitant","L-754,030","MK-0869","MK-869","NSC-748825"],"crossReferences":{"DailyMed":["aprepitant"],"Wikipedia":["Aprepitant"],"drugbank":["DB00673"],"chEBI":["499361"]},"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0004240","EFO_0002610","HP_0000989","MONDO_0002009","MONDO_0007254","EFO_1000948","HP_0002018","EFO_0000565","EFO_0007191","EFO_0003144","HP_0002017","HP_0002013","EFO_0000514","MONDO_0007079","MONDO_0002715","EFO_0000616","EFO_0006911","MONDO_0008170","EFO_0000222","EFO_0003843","EFO_0003060","EFO_0000311","MONDO_0100096","EFO_0000764","EFO_0004888","EFO_0000574","EFO_0001378","EFO_0005611","EFO_0000519"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 5 approved and 17 investigational indications."}
{"id":"CHEMBL164","canonicalSmiles":"O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"IKMDFBPHZNJCSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MYRICETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-407290"],"crossReferences":{"PubChem":["11111487","11111488","11111489","124880771","124880773","124880776","124880777","124880778","26753603","26753604","477075","50106561","50106562","50124232","56463598","85231140","90341245"],"Wikipedia":["Myricetin"],"drugbank":["DB02375"],"chEBI":["18152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1823872","canonicalSmiles":"C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O","inchiKey":"NHXLMOGPVYXJNR-ATOGVRKGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SOMATOSTATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SRIF-14","Somatostatin"],"crossReferences":{"drugbank":["DB09099"],"chEBI":["64628"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL18602","canonicalSmiles":"CCCCC=O","inchiKey":"HGBOYTHUEUWSSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTANAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentanal"],"crossReferences":{"PubChem":["144210381","17389654"],"drugbank":["DB01919"],"chEBI":["84069"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186200","canonicalSmiles":"O=[N+]([O-])[O-]","inchiKey":"NHNBFGGVMKEFGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL186200","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14049"],"chEBI":["17632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1951914","canonicalSmiles":"CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1","inchiKey":"QOSMEMHKXNNIGG-SSEXGKCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD5672","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5672","AZD5672","Azd 5672","Azd-5672","Azd5672"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000685"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2007389","canonicalSmiles":"CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12.Cl","inchiKey":"LAOOXBLMIJHMFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCANTHONE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL279014","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["79 T61","79-T61","Lucanthone hcl","Lucanthone hydrochloride","MS-752","Miracil d","Miracol","NSC-14574","Nilodin","RP-3735","Tixantone"],"crossReferences":{"PubChem":["540758"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2021342","canonicalSmiles":"Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2","inchiKey":"MSTNYGQPCMXVAQ-KIYNQFGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2021342","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00116"],"chEBI":["20506"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2021424","canonicalSmiles":"O=S(=O)([O-])[O-].[K+].[K+]","inchiKey":"OTYBMLCTZGSZBG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM SULFATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pot sulf"],"synonyms":["Arcanum duplicatum","E-515(I)","INS NO.515(I)","INS-515(I)","Kali sulphuricum","Potassium (as sulfate)","Potassium sulfate","Sal polychrestum","Sulfuric acid, dipotassium salt","Tartarus vitriolatus"],"crossReferences":{"drugbank":["DB14499"],"chEBI":["32036"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2010."}
{"id":"CHEMBL2062335","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"YGULWPYYGQCFMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOPROLOL TARTRATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arbralene","Beloc cor","Betaloc","Betaloc s.a.","Lopresor","Lopresor sr","Lopressor","Mepranix 100","Mepranix 50","Metoprolol tartrate","Tensomex","Toprol xl"],"synonyms":["Beloc","CGP-2175E","Metoprolol hemitartrate","Metoprolol tartrate","Metropress","NSC-757105","Prelis","Seloken","Selopral"],"crossReferences":{"DailyMed":["metoprolol%20tartrate"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0004269","EFO_0003144","EFO_0001645","EFO_0000712","EFO_0000612","EFO_0000537","EFO_0003913"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 5 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2096647","drugType":"Small molecule","blackBoxWarning":false,"name":"LANTHANUM CARBONATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosrenol"],"synonyms":["BAY77-1931","Dilanthanum tricarbonate hydrate","Foznol","Lanthanum carbonate","Lanthanum carbonate (la2(co3)3)","Lanthanum carbonate anhydrous","Lanthanum carbonate hydrate","Lanthanum carbonate pentahydrate","Lanthanum carbonate tetrahydrate","Lanthanum sesquicarbonate","Lanthanum(3 ) carbonate","Phosbloc"],"crossReferences":{"DailyMed":["lanthanum%20carbonate"],"DrugCentral":["4585"]},"childChemblIds":["CHEMBL1909302"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for chronic kidney disease and has 2 investigational indications."}
{"id":"CHEMBL2104344","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Na+]","inchiKey":"UEUXEKPTXMALOB-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETATE SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calsol","Complexone","Edetate","Edetate sodium","Edta sodium","Edta tetrasodium","Edta tetrasodium salt","Edta, tetrasodium","Endrate tetrasodium","Nervanaid","Nullapo","Sodium edta","Syntes 12a","Tetrasodium edetate","Tetrasodium edta","Trilon b","Versene 100"],"crossReferences":{"drugbank":["DB13404"]},"childChemblIds":["CHEMBL1871697"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104744","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](C)C[C@@]21C","inchiKey":"IWSXBCZCPVUWHT-VIFKTUCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTOMET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norgestomet","SC-21009"],"crossReferences":{"drugbank":["DB11440"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105181","canonicalSmiles":"C=C(C#N)C(=O)OCCCCCCCC","inchiKey":"RPQUGMLCZLGZTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCRYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-octyl cyanocrylate","Ocrilate","Ocrylate"],"crossReferences":{"drugbank":["DB15086"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105695","canonicalSmiles":"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1","inchiKey":"MDSQOJYHHZBZKA-GBXCKJPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELOTRISTAT ETHYL","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xermelo"],"synonyms":["LX 1032","LX 1606","LX-1032","LX-1606","LX1032","LX1606","Telotristat ethyl"],"crossReferences":{"DailyMed":["telotristat%20etiprate"],"drugbank":["DB12095"]},"childChemblIds":["CHEMBL3348963"],"linkedTargets":{"rows":["ENSG00000139287","ENSG00000129167"],"count":2},"linkedDiseases":{"rows":["MONDO_0003060","EFO_1001769","EFO_1000044","EFO_1001901","HP_0002014","MONDO_0002995","EFO_0001421","EFO_1000852"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for diarrhea and has 5 investigational indications."}
{"id":"CHEMBL2105759","canonicalSmiles":"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1","inchiKey":"XUZMWHLSFXCVMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BARICITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olumiant"],"synonyms":["Baricitinib","Baricitinib phosphate","Baricitinib phosphate salt","INCB-028050","INCB028050","Incb-28050","LY-3009104","LY3009104"],"crossReferences":{"DailyMed":["baricitinib"],"drugbank":["DB11817"]},"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000694","EFO_0000685","EFO_1000668","EFO_0000401","EFO_0000274","EFO_0000540","EFO_1001486","EFO_0002609","EFO_0003106","EFO_1001209","EFO_1001231","MONDO_0100096","EFO_0004192","EFO_0002690","EFO_1001999","EFO_0000398","MONDO_0005147","EFO_0003884","EFO_0000783","EFO_0000676","EFO_0004208","EFO_1000726","EFO_0000699"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for rheumatoid arthritis and immune system disease and has 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106424","canonicalSmiles":"C=C(C#N)C(=O)OC","inchiKey":"MWCLLHOVUTZFKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECRYLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aron alpha a","Cyanoacrylate","Mecrilate","Mecrylate","Methyl cyanoacrylate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107294","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C/C(=C1/c3ccccc3CSc3ccccc31)C2","inchiKey":"JOQKFRLFXDPXHX-YFUWWQDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPATEPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SD 1248-17 [AS HYDROCHLORIDE]","Tropatepine"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107774","canonicalSmiles":"CCc1ccc(Nc2c(F)c(F)cc(F)c2F)c(CC(=O)O)c1","inchiKey":"ZEXGDYFACFXQPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROBENACOXIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGS 34975","Onsior","Robenacoxib"],"crossReferences":{"drugbank":["DB11455"],"chEBI":["76269"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108678","drugType":"Antibody","blackBoxWarning":false,"name":"NESVACUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Regn910"],"synonyms":["Nesvacumab","REGN-910","REGN910"],"linkedTargets":{"rows":["ENSG00000091879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001365","EFO_0009321"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108709","drugType":"Enzyme","blackBoxWarning":false,"name":"COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Santyl","Xiaflex"],"synonyms":["AA-4500","AA4500","Clostridial collagenase","Clostridium histolyticum enzymes","Collagenase","Collagenase (clostridium histolyticum)","Collagenase clostridium histolyticum","Cordase","Iruxol","MZ-004","Plaquase"],"crossReferences":{"DailyMed":["collagenase%20clostridium%20histolyticum"],"DrugCentral":["5051"]},"linkedTargets":{"rows":["ENSG00000108821","ENSG00000204248","ENSG00000060718","ENSG00000188153","ENSG00000168542","ENSG00000164692","ENSG00000142156","ENSG00000081052","ENSG00000206384","ENSG00000163359","ENSG00000204262","ENSG00000172752","ENSG00000169031","ENSG00000080573","ENSG00000197565","ENSG00000142173","ENSG00000215018","ENSG00000204291","ENSG00000130635","ENSG00000171502","ENSG00000196739","ENSG00000139219","ENSG00000182871","ENSG00000134871","ENSG00000187498"],"count":25},"linkedDiseases":{"rows":["EFO_0000759","HP_0200042","HP_0012227","EFO_0007067","EFO_0009516","MONDO_0043839","EFO_1000941","EFO_0005756","EFO_0003899","EFO_0004229","EFO_1001459","HP_0003549","EFO_1001434","EFO_1000466"],"count":14},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL2108769","drugType":"Unknown","blackBoxWarning":false,"name":"SAW PALMETTO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abal fructus","Brahea serrulata fruit","Chamaerops serrulata fruit","Corypha obliqua fruit","Corypha repens fruit","Diglossophyllum serrulatum fruit","Sabal palm fruit","Sabal serrulata","Sabal serrulata fruit","Saw palmetto","Saw palmetto berry","Saw palmetto fruit","Saw palmetto whole","Serenoa","Serenoa repens","Serenoa repens fruit","Serenoa repens fruit dry extract","Serenoa repens fruit ethanol extract","Serenoa repens whole","Serenoa serrulata fruit","Serenoa serrulata fruit powder"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108779","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYCARBOPHIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Noveon aa-1"],"synonyms":["Polycarbokane","Polycarbophil"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108885","drugType":"Unknown","blackBoxWarning":false,"name":"ACTOVEGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actovegin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108905","drugType":"Unknown","blackBoxWarning":false,"name":"BCG VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tice bcg"],"synonyms":["Bacillus calmette-guerin antigen","Bacillus calmette-guerin vaccine","Bcg vaccine","Bcg vaccine, live","Tuberculosis vaccine"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL2108955","drugType":"Antibody","blackBoxWarning":false,"name":"EDRECOLOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panorex"],"synonyms":["17-1A","C-1","Edrecolomab","MAB-17-1A"],"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000364","EFO_1001951","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109121","drugType":"Unknown","blackBoxWarning":false,"name":"DIPHTHERIA TOXOID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphtheria toxoid"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL210952","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AURFZBICLPNKBZ-YZRLXODZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELTANOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eltanolone","KABI 2213","KABI-2213","NSC-82867","Pregnan-3.alpha.-ol-20-one","Pregnanolone","SKF-6455"],"crossReferences":{"drugbank":["DB12308"],"chEBI":["1712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110573","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIUM OXYQUINOLINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["indium%20in-111%20oxyquinoline"]},"childChemblIds":["CHEMBL1200452"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL2111066","canonicalSmiles":"CC(CN1c2ccccc2Sc2cccnc21)N(C)C","inchiKey":"OQJBSDFFQWMKBQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOTHIPENDYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-56012","Actapront","D-201","Isothipendyl","Odantol","Udantol"],"crossReferences":{"drugbank":["DB08802"]},"childChemblIds":["CHEMBL2107246"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2158051","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O","inchiKey":"LSXUTRRVVSPWDZ-MKKUMYSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-406","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-406","At-406","D-1143","DEBIO 1143","DEBIO-1143","Debio 1143","IAP INHIBITOR AT-406","SM-406","Xevinapant"],"childChemblIds":["CHEMBL2158055"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2181753","canonicalSmiles":"CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)NCc1ccccc1","inchiKey":"OPXIRFWNLBDKQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AM-211","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM211","Am-211"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2220442","canonicalSmiles":"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21","inchiKey":"FJLGEFLZQAZZCD-VAWYXSNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUVASTATIN","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fluvas","Fluvastatin","NSC-758896"],"crossReferences":{"DailyMed":["fluvastatin%20sodium"],"chEBI":["38562"]},"childChemblIds":["CHEMBL2218894"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0002689","HP_0003124","EFO_0000756","EFO_0001645","HP_0000802","MONDO_0007254","EFO_0000319","EFO_0000266","EFO_0003882","EFO_0004911","MONDO_0008315","Orphanet_309005","EFO_0000537","Orphanet_63","EFO_0000195","EFO_0000589","EFO_0004220","EFO_0002614","EFO_0000326","EFO_0003047"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved and 12 investigational indications."}
{"id":"CHEMBL223026","canonicalSmiles":"Oc1ccc(-c2n[nH]c3cc(O)ccc23)c(O)c1","inchiKey":"WLDZDEMGKFWJNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223026","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08048"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2333941","canonicalSmiles":"C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1","inchiKey":"MJQMRGWYPNIERM-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2811376","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.079.793K","LY2811376","Ly-2811376","Ly2811376"],"crossReferences":{"drugbank":["DB13065"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2374961","canonicalSmiles":"CC1=CC[C@@H](C(C)(C)O)C[C@@H]1O","inchiKey":"OMDMTHRBGUBUCO-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2374961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13315"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL239129","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGLUMINE ANTIMONATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glucantim","Glucantime","Meglumine Antimonate","Meglumine antimonate","Meglumine antimoniate","N-methylglucamine antimonate"],"crossReferences":{"DrugCentral":["1669"],"Wikipedia":["Meglumine_antimoniate"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL23996","canonicalSmiles":"O=C1CCCC(=O)C1=C(O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]","inchiKey":"PMHVFNYNPNKNRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL23996","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243940","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2cccc(NC3CCCCC3)c2)c1Br","inchiKey":"RXDVFLTWXCTCEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06829"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25164","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","inchiKey":"BJDCWCLMFKKGEE-HVDUHBCDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL25164","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Dihydroartemisinin"],"drugbank":["DB11638"],"chEBI":["207229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25263","canonicalSmiles":"O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O","inchiKey":"HZLAWYIBLZNRFZ-VXGBXAGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRIDESAP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPHPC","Cphpc","GSK-2315698","GSK2315698","Gsk2315698","Miridesap","RO-638695","Ro 63-8695"],"crossReferences":{"Wikipedia":["CPHPC"],"drugbank":["DB13087"]},"linkedTargets":{"rows":["ENSG00000132703"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","EFO_1001875","Orphanet_314701"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL257695","canonicalSmiles":"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"OIFWQOKDSPDILA-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIDOTHYMIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zidovudine Monophosphate"],"crossReferences":{"drugbank":["DB03666"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261777","canonicalSmiles":"c1ccc(-c2ncc(-c3cc[nH]n3)s2)cc1","inchiKey":"NRAHRUHGPGBWSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL261777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817033"],"drugbank":["DB07614"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL263376","canonicalSmiles":"NC(=S)Nc1ccccc1","inchiKey":"FULZLIGZKMKICU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLTHIOUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Phenylthiourea","N-Phenyl-Thiourea","N-Phenylthiourea","Phenylthiourea"],"crossReferences":{"PubChem":["144208880","144213315","17388780","17389761","26752856"],"drugbank":["DB03694"],"chEBI":["46261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286497","canonicalSmiles":"O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2c(c1)CNCC2","inchiKey":"UVSIFVBCHJEYJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL286497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08631"]},"childChemblIds":["CHEMBL1788154"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL300337","canonicalSmiles":"COc1ccc(C[C@H](NC(=O)CC(C)(C)N)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CC(C)C)cc1","inchiKey":"KQXVERRYBYGQJZ-WRPDIKACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENALKIREN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-64662","ABBOTT-64662","Enalkiren"],"crossReferences":{"drugbank":["DB03395"],"chEBI":["4787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301267","canonicalSmiles":"CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3","inchiKey":"NLYNIRQVMRLPIQ-XQLAAWPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMOTIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".beta.-arteether","Arteether","Artemotil","Artemotilum","NSC-665971"],"crossReferences":{"Wikipedia":["Artemotil"],"drugbank":["DB13851"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for malaria."}
{"id":"CHEMBL3039517","canonicalSmiles":"Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1","inchiKey":"SYYBDNPGDKKJDU-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABUSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IC-83","LY-2603618","LY2603618","Ly-2603618","Rabusertib"],"crossReferences":{"drugbank":["DB11662"]},"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003860","EFO_0003060","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3137313","canonicalSmiles":"NC(=O)c1cccc([C@@H]2C[C@@H]3CC[C@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1","inchiKey":"ATLYLVPZNWDJBW-KIHHCIJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXELOPRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axelopran","TD-1211"],"crossReferences":{"drugbank":["DB12013"]},"childChemblIds":["CHEMBL3137319","CHEMBL3895543"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3188202","canonicalSmiles":"CCCCCON=O","inchiKey":"CSDTZUBPSYWZDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188202","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210096"],"drugbank":["DB01612"],"chEBI":["55344"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3228489","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c(=O)[nH]1","inchiKey":"UIYWFOZZIZEEKJ-PXBUCIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3228489","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328910","canonicalSmiles":"O=C(O)c1ccc(O)cc1O","inchiKey":"UIAFKZKHHVMJGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,4-DIHYDROXYBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4-Dihydroxy-Benzoic Acid","2,4-Dihydroxybenzoic Acid","Beta-Resorcylic Acid"],"crossReferences":{"PubChem":["144209669","17389146","17389389","56314872"],"Wikipedia":["2,4-Dihydroxybenzoic_acid"],"drugbank":["DB02839"],"chEBI":["89942"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301625","canonicalSmiles":"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1","inchiKey":"KXBDTLQSDKGAEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPEBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVL-292","Btk inhibitor cc-292","CC-292","Spebrutinib"],"crossReferences":{"drugbank":["DB11764"]},"childChemblIds":["CHEMBL3301600"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0009441","EFO_0000685","EFO_0000095","EFO_0000403"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3301680","canonicalSmiles":"CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.Cl","inchiKey":"GSSIWSIRBWAZHG-ACOPVEIWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELAVANCIN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL507870","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vibativ"],"synonyms":["TD-6424","Telavancin hcl","Telavancin hydrochloride","Televancin hydrochloride"],"crossReferences":{"DailyMed":["telavancin%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for bacterial pneumonia and infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3334624","canonicalSmiles":"Cc1cc(C[C@@H](OC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCOCC3)CC2)cc(C)c1O","inchiKey":"HTLWMOKBJQKDIJ-WJOKGBTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-44370","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 44370 TA","BI-44370-BS","Bi 44370 ta","Bi-44370","J3.353.239C"],"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL337450","canonicalSmiles":"N#C[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O","inchiKey":"DCYBPMFXJCWXNB-JWIUVKOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-109","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cndac","Deoxycytidine analogue tas-109","Radgocitabine","Tas 109","Tas-109"],"crossReferences":{"drugbank":["DB11667"]},"childChemblIds":["CHEMBL1204346"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL338667","canonicalSmiles":"O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1","inchiKey":"YUGZHQHSNYIFLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPERODON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diperodon","Diperodon anhydrous"],"crossReferences":{"PubChem":["29217900"],"drugbank":["DB11513"]},"childChemblIds":["CHEMBL1456312"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545030","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-17216498","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-17216498"],"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545136","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00337210","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-00337210","Pf-337210"],"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545403","canonicalSmiles":"CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1","inchiKey":"KLRRGBHZCJLIEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-833923","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-833923","BMS-833923 DIMESYLATE MONOHYDRATE","Bms-833923","XL-139","XL139"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0003897","Orphanet_377","EFO_0002916","EFO_0000702","EFO_0004193","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL354676","canonicalSmiles":"O=C(Nc1ccccc1)Nc1ccccc1","inchiKey":"GWEHVDNNLFDJLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3-Diphenyl-Urea","1,3-Diphenylurea"],"crossReferences":{"PubChem":["103904380","103904397","144207266","17389030","26747341","93576666"],"drugbank":["DB07496"],"chEBI":["41320"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL370100","canonicalSmiles":"CO[C@@H]1[C@@H](CO)O[C@@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H]1O","inchiKey":"QEHOIJJIZXRMAN-QZQSLCQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBECCAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rebeccamycin"],"crossReferences":{"Wikipedia":["Rebeccamycin"],"drugbank":["DB14729"],"chEBI":["135511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL37161","canonicalSmiles":"COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1","inchiKey":"HDDSHPAODJUKPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panacur"],"synonyms":["Fenbendazole","Fenbendazole for veterinary use","HOE 881V","HOE 881Y","HOE-881V","HOE-881Y","NSC-757824","Panacur aquasol"],"crossReferences":{"PubChem":["11112769","124882602","144204200","144212145","170465647","174006199","26746977","855748"],"Wikipedia":["Fenbendazole"],"drugbank":["DB11410"],"chEBI":["77092"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL376488","canonicalSmiles":"COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12","inchiKey":"QUIJNHUBAXPXFS-XLJNKUFUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BEDAQUILINE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sirturo"],"synonyms":["Bedaquiline","R-207910","R207910","TMC-207","TMC207"],"crossReferences":{"DailyMed":["bedaquiline%20fumarate"],"drugbank":["DB08903"],"chEBI":["72292"]},"childChemblIds":["CHEMBL4524943","CHEMBL2105700"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for tuberculosis and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL377559","canonicalSmiles":"C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)N2.Cl","inchiKey":"OIRUWDYJGMHDHJ-AFXVCOSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETASPIMYCIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1184904","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPI-504","IPI-504 HYDROCHLORIDE","Retaspimycin hcl","Retaspimycin hydrochloride"],"crossReferences":{"chEBI":["71956"]},"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["MONDO_0008903","Orphanet_44890","EFO_0000673","MONDO_0007254","EFO_0001378","EFO_0000305","EFO_0003060","EFO_0003085","EFO_0002617","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3915620","canonicalSmiles":"CC#C[C@@H](CC(=O)O)c1ccc(OCc2ccc(CN3CCC4(C=Cc5ccccc54)CC3)cc2)cc1","inchiKey":"FHRWHNJJQGSCQC-LJAQVGFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3915620","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3945401","canonicalSmiles":"O=S(=O)(O)O[C@H]1[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O","inchiKey":"NBTMNFYXJYCQHQ-GPIVLXJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3945401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01666"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989541","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccc(OC)cc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"ULBNWNUHGJLQHO-VKMIBBQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOSERPIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-10-methoxydeserpidine","10-md","10-methoxydeserpidine","Deaserpyl","Decaserpil","Decaserpin","Decaserpine","Decaserpyl","Decoserpyl","Deserpidine, 10-methoxy-","Methoserpidine","Minoran","NSC-169423","Neoserpin","R 694","R-694","Resertene","Tenserpina"],"crossReferences":{"drugbank":["DB13631"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989680","canonicalSmiles":"COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1","inchiKey":"LQJLLAOISDVBJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXOMADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axomadol","BN-110 FREE BASE","BN110 BASE","BN110 FREE BASE","En3324","GRT-151 FREE BASE","GRT0151Y","GRT151 Base","GRT151 FREE BASE"],"childChemblIds":["CHEMBL3976339"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","HP_0003419","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989686","canonicalSmiles":"CN1CCCC[C@H]1CCc1ccccc1NC(=O)/C=C/c1ccccc1","inchiKey":"UXIPFQUBOVWAQW-UEBLJOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IFERANSERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iferanserin","Ven-309"],"crossReferences":{"drugbank":["DB11686"]},"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0009552"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989938","canonicalSmiles":"COC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(N[C@@H](C)C(=O)OC)Oc1ccccc1","inchiKey":"HUWUHKIPYXWUPN-YVRVQSMLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSMETPANTOTENATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosmetpantotenate","RE-024"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL400520","canonicalSmiles":"OCc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12","inchiKey":"RBLKWWBHDUBPFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400520","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06983"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL419667","canonicalSmiles":"COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC","inchiKey":"CEBYCSRFKCEUSW-NAYZPBBASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELCOVAPTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Relcovaptan","SR 49059","Sr-49059","TDI 0134","TDI-0134"],"crossReferences":{"PubChem":["26753276"],"Wikipedia":["Relcovaptan"],"drugbank":["DB13929"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4207489","canonicalSmiles":"N#Cc1cc(NC(=O)[C@H]2c3ccccc3C(=O)N(CC(F)(F)F)[C@@H]2c2cccnc2)ccc1F","inchiKey":"VKCPFWKTFZAOTO-LEWJYISDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SJ-733","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SJ733","Sj-733","Sj733"],"crossReferences":{"drugbank":["DB12659"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297473","canonicalSmiles":"Cc1occc1C(=O)Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2ccccc12","inchiKey":"XLLRLAABUFOJPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NP-G2-044","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NP-G2-044","Np-g2-044"],"crossReferences":{"drugbank":["DB14995"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297502","canonicalSmiles":"C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2ccc(C(=O)NCC3CC3)nc2C(=O)O)cc1OC","inchiKey":"TUWMKPVJGGWGNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVORALSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avoralstat","BCX-4161"],"crossReferences":{"drugbank":["DB12120"]},"linkedTargets":{"rows":["ENSG00000164344"],"count":1},"linkedDiseases":{"rows":["Orphanet_91378"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297588","canonicalSmiles":"CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(=O)O)c3ccc(O)cc3)cc2S(=O)(=O)N1","inchiKey":"XULSCZPZVQIMFM-IPZQJPLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODEVIXIBAT","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bylvay"],"synonyms":["A-4250","A4250","AR-H064974","AZD-8294","AZD8294","Odevixibat","Odevixibat sesquihydrate"],"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["Orphanet_30391","Orphanet_79304","HP_0000989","MONDO_0001751","EFO_0004267","Orphanet_172","Orphanet_284385","EFO_1001249","Orphanet_79306","Orphanet_52"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for familial intrahepatic cholestasis and pruritus and has 5 investigational indications."}
{"id":"CHEMBL4297828","drugType":"Unknown","blackBoxWarning":false,"name":"SHR-1316","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adebrelimab","HTI-1088","SHR-1316","Shr-1316"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4298077","drugType":"Antibody","blackBoxWarning":false,"name":"PRASINEZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRX002","Prasinezumab","Prx-002","Prx002","RG-7935","RG7935","RO-7046015","RO7046015","Ro7046015"],"linkedTargets":{"rows":["ENSG00000145335"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4299960","canonicalSmiles":"O=O.[O-][Cl+]O.[O-][Cl+]O.[O-][Cl+]O.[O-][Cl+]O","inchiKey":"IVFGWWGNVIZDAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACHLORODECAOXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3707387"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL430497","canonicalSmiles":"Clc1ccc(OC[C@H]2CCN2)cn1","inchiKey":"MKTAGSRKQIGEBH-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEBANICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tebanicline"],"childChemblIds":["CHEMBL2104964"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL436462","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"MWEWSHNGVWABKG-SVBPBHIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL436462","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01908"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455186","canonicalSmiles":"CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O","inchiKey":"YCPOZVAOBBQLRI-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREOSULFAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Grafapex","Graftrevo","Kepcondi","Ovastat","Trecondi","Trecondyv","Treograft"],"synonyms":["NSC-39069","Threosulphan","Treosulfan"],"crossReferences":{"drugbank":["DB11678"],"chEBI":["82557"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 13 investigational indications."}
{"id":"CHEMBL458875","canonicalSmiles":"Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O","inchiKey":"GBBJCSTXCAQSSJ-XQXXSGGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEVUDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clevudine","L-FMAU","Levovir"],"crossReferences":{"Wikipedia":["Clevudine"],"drugbank":["DB06683"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594521","drugType":"Antibody","blackBoxWarning":false,"name":"ELUVIXTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 330","AMG-330","AMG330","Amg 330","Amg-330","Eluvixtamab"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594550","drugType":"Antibody","blackBoxWarning":false,"name":"SERPLULIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HLX-10","HLX10","Hlx10","Serplulimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_1001480","EFO_0005922","MONDO_0002974","EFO_0000182","EFO_0000702","MONDO_0007254","EFO_0003060","EFO_0000181","EFO_1001951"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL462394","canonicalSmiles":"CC(=O)Nc1c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c(I)c(N(C)C(C)=O)c1I","inchiKey":"BAQCROVBDNBEEB-UBYUBLNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRIZAMIDE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amipaque"],"synonyms":["Metrizamide","Telebrix 300","WIN 39103","WIN-39103"],"crossReferences":{"PubChem":["144204170"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL4650249","drugType":"Antibody","blackBoxWarning":false,"name":"IMDEVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imdevimab","REGN-10987","REGN10987"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650451","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TADNERSEN SODIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-078","BIIB078","Biib078","Tadnersen sodium"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650487","drugType":"Antibody","blackBoxWarning":false,"name":"TORUDOKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3375880","LY3375880","Ly3375880","Torudokimab"],"linkedTargets":{"rows":["ENSG00000137033"],"count":1},"linkedDiseases":{"rows":["EFO_0000274"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL473159","canonicalSmiles":"Oc1cc(O)cc(O)c1","inchiKey":"QCDYQQDYXPDABM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHLOROGLUCINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spasfon","Spasfon-lyoc"],"synonyms":["Benezene-1,3,5-triol","Dilospan s","NSC-1572","Phloroglucin","Phloroglucinol","Sym-trihydroxybenzene"],"crossReferences":{"PubChem":["29218028"],"Wikipedia":["Phloroglucinol"],"drugbank":["DB12944"],"chEBI":["16204"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL474637","canonicalSmiles":"Cc1cc(N)nc(C[C@H]2CNC[C@H]2NCCNCc2ccc(Cl)cc2)c1","inchiKey":"JDRSQGJWTVRNGM-QFBILLFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL474637","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08018"]},"childChemblIds":["CHEMBL481815"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802142","canonicalSmiles":"CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(=O)O","inchiKey":"DXRXYJYFADHAPA-AUTRQRHGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"EA-230","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ea-230","Nmpf-46"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL485980","canonicalSmiles":"CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC","inchiKey":"CJGYSWNGNKCJSB-YVLZZHOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLADESINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucladesine","Bucladesine sodium","Dibutyryl camp","NSC-143108"],"crossReferences":{"PubChem":["11113333","144204415","26751474"],"Wikipedia":["Bucladesine"],"drugbank":["DB13242"],"chEBI":["50095"]},"childChemblIds":["CHEMBL1522836","CHEMBL1876736"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL487182","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2","inchiKey":"AEQDJSLRWYMAQI-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROPALMATINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-corydalis b","(-)-rotundine","(-)-tetrahydropalmatine","Caseanine","Gindarine","Hyndarine","L-Tetrahydropalmatine","Levo-tetrahydropalmatine","Rotundine","Tetrahydropalmatine","Tetrahydropalmatine l-form","Tetrahydropalmatine, (-)-","Tetrahydropalmatine, dl-","Tetrahydropalmatine, l-"],"crossReferences":{"Wikipedia":["Tetrahydropalmatine"],"drugbank":["DB12093"],"chEBI":["16563"]},"childChemblIds":["CHEMBL1359254"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL491019","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1","inchiKey":"SVMHTBVIPYVDIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1107","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-1107"],"crossReferences":{"drugbank":["DB08459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL493982","canonicalSmiles":"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1","inchiKey":"ZBGXUVOIWDMMJE-QHNZEKIYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORAPAXAR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["SCH-530348","Vorapaxar"],"crossReferences":{"DailyMed":["vorapaxar%20sulfate"],"Wikipedia":["Vorapaxar"],"drugbank":["DB09030"],"chEBI":["82702"]},"childChemblIds":["CHEMBL2107386","CHEMBL3542336"],"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","EFO_0000712","EFO_0001645","MONDO_0002679","EFO_0000612","HP_0004419","EFO_0005672","EFO_0004265"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 4 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL502630","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C","inchiKey":"XWQVQFBTSBCKLI-FKXNDIMNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NERINETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FN-023","FN023","NA-1","Nerinetide","Tat-nr2b9c"],"childChemblIds":["CHEMBL4594282","CHEMBL4594283"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL516","canonicalSmiles":"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1","inchiKey":"JJCFRYNCJDLXIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROHEPTADINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ciprovit","Cyproheptadine"],"crossReferences":{"DailyMed":["cyproheptadine%20hydrochloride"],"PubChem":["104171133","11110964","11110965","11113362","124879679","144203663","170465127","174007288","26751603","50100203","50104260","90341656"],"Wikipedia":["Cyproheptadine"],"drugbank":["DB00434"],"chEBI":["4046"]},"childChemblIds":["CHEMBL1716"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0002027","EFO_0005531","MONDO_0100096","EFO_0000712","MONDO_0005271","EFO_0007141","MONDO_0007079","EFO_0003956","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL539843","canonicalSmiles":"Cl.Cl.NC(=O)c1cnc2n1CCc1ccccc1C21CCNCC1","inchiKey":"BOYLPLUVCXUHDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAPITADINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL369075","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hivenyl"],"synonyms":["R-129160","R129160","Vapitadine dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL565612","canonicalSmiles":"CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1","inchiKey":"OAVGBZOFDPFGPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTRASTAURIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEB-071","AEB071","Aeb-071","NVP-AEB071","Sotrastaurin"],"crossReferences":{"PubChem":["103905056"],"drugbank":["DB12369"],"chEBI":["90531"]},"childChemblIds":["CHEMBL2105655"],"linkedTargets":{"rows":["ENSG00000154229","ENSG00000065675","ENSG00000171132","ENSG00000126583","ENSG00000067606","ENSG00000163932","ENSG00000166501","ENSG00000163558","ENSG00000027075","ENSG00000115825","ENSG00000184304"],"count":11},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000616","EFO_0000403","EFO_0000574","EFO_0000676","EFO_1001119"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL573306","canonicalSmiles":"COc1cc([C@H](C)C#Cc2c(C)nc(N)nc2N)ccc1-c1ccccc1","inchiKey":"YYCPXVRHQUEVAW-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL573306","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06847"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL575448","canonicalSmiles":"C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1","inchiKey":"LQVXSNNAFNGRAH-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-754807","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-754807","Bms-754807"],"crossReferences":{"PubChem":["164339435"],"drugbank":["DB15399"],"chEBI":["88339"]},"childChemblIds":["CHEMBL2401777"],"linkedTargets":{"rows":["ENSG00000140443","ENSG00000171105"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL589092","canonicalSmiles":"O=C(O)Cc1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1","inchiKey":"JIEKMACRVQTPRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTIAZAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fentiazac","NSC-282191","WY-21,894","WY-21894"],"crossReferences":{"PubChem":["124894583","144205341","144206769","144206770","170466003","99360853"],"drugbank":["DB13217"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL596802","canonicalSmiles":"CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1","inchiKey":"YGKUEOZJFIXDGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIDOPIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Huntexil"],"synonyms":["ACR-16","ACR16","FR-310826","FR310826","Pridopidine"],"crossReferences":{"drugbank":["DB11947"]},"childChemblIds":["CHEMBL2105691"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","MONDO_0005180","MONDO_0004976"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL621","canonicalSmiles":"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12","inchiKey":"PHLBKPHSAVXXEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAZODONE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Desyrel","J10.767K","Trazodone","Trialodine","Trittico"],"crossReferences":{"DailyMed":["trazodone%20hydrochloride"],"PubChem":["11111900","11111901","174007449","90341328"],"Wikipedia":["Trazodone"],"drugbank":["DB00656"],"chEBI":["9654"]},"childChemblIds":["CHEMBL1200798"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005687","MONDO_0002009","HP_0000726","EFO_0009267","EFO_0008568","EFO_0004698","EFO_1000783","MONDO_0002050","MONDO_0004975","EFO_0003761","MONDO_0004976","MONDO_0007079","EFO_0003918","EFO_0005230"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL669","canonicalSmiles":"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21","inchiKey":"JURKNVYFZMSNLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBENZAPRINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclobenzaprine","Flexeril","MK-130 (AS THE BASE)","TNX-102"],"crossReferences":{"DailyMed":["cyclobenzaprine%20hydrochloride"],"PubChem":["11110649","11110650","174007219","4253288","50108641","50111010","90340629"],"Wikipedia":["Cyclobenzaprine"],"drugbank":["DB00924"],"chEBI":["3996"]},"childChemblIds":["CHEMBL1200636"],"linkedTargets":{"rows":["ENSG00000102468","ENSG00000147246"],"count":2},"linkedDiseases":{"rows":["HP_0001257","MONDO_0005277","HP_0003326","EFO_0001422","EFO_0005687","MONDO_0002050","EFO_0009488","EFO_1000632","HP_0003419","EFO_0001358","HP_0003394","EFO_0003843"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 approved and 6 investigational indications."}
{"id":"CHEMBL77996","canonicalSmiles":"O=P(O)(O)/C=C/CCSc1ccccc1O","inchiKey":"GHNIEXOPSISMGX-XVNBXDOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL77996","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07890"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL84","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1","inchiKey":"UCFGDBYHRUNTLO-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOPOTECAN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hycamtin","Potactasol"],"synonyms":["Hycamptamine","Hycamptin","Hycamtin","NSC-609699","NSC-641007","Nogitecan","SKF-104864","Topotecan"],"crossReferences":{"DailyMed":["topotecan%20hydrochloride"],"PubChem":["164339428"],"Wikipedia":["Topotecan"],"drugbank":["DB01030"],"chEBI":["63632"]},"childChemblIds":["CHEMBL1607"],"linkedTargets":{"rows":["ENSG00000184428"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001075","EFO_0003859","EFO_0000681","MONDO_0000956","EFO_1000657","MONDO_0004222","EFO_0005952","EFO_0005561","EFO_0000565","MONDO_0002974","EFO_1001331","MONDO_0008903","EFO_0000389","EFO_1000251","EFO_0002918","Orphanet_654","EFO_0001416","EFO_0000198","EFO_0003893","MONDO_0037745","EFO_0000466","MONDO_0018271","EFO_1000823","EFO_0000220","MONDO_0008170","EFO_0000502","MONDO_0008315","Orphanet_357034","EFO_0000630","Orphanet_398934","EFO_0001061","MONDO_0100096","EFO_1001100","EFO_0003851","EFO_0008524","EFO_0002428","EFO_0000574","MONDO_0002380","EFO_0001378","EFO_1000172","MONDO_0100342","MONDO_0015686","EFO_1001465","MONDO_0007254","Orphanet_790","EFO_0002087","MONDO_0021063","MONDO_0002087","EFO_0000305","EFO_1000357","EFO_0007362","MONDO_0002158","EFO_1000043","MONDO_0012825","EFO_0000326","EFO_0002499","EFO_1001963","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0008498","EFO_1001042","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","EFO_0000613","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000174","MONDO_0011962","EFO_0000702","EFO_1002008","MONDO_0019004","EFO_1000895","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0024880"],"count":81},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 9 approved and 63 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL895","canonicalSmiles":"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"NETZHAKZCGBWSS-CEDHKZHLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALBUPHINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Intapan","Nalbuphine","Nubain"],"crossReferences":{"DailyMed":["nalbuphine%20hydrochloride"],"PubChem":["144205561"],"Wikipedia":["Nalbuphine"],"drugbank":["DB00844"],"chEBI":["7454"]},"childChemblIds":["CHEMBL1396398","CHEMBL1201132"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["MONDO_0026045","HP_0000989","EFO_0005323","MONDO_0005271","MONDO_0000870","HP_0000175","EFO_0000222","EFO_0009267","EFO_0003843","HP_0000713","HP_0003040","EFO_0001421","EFO_0005611","EFO_1001250"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and has 8 investigational indications."}
{"id":"CHEMBL923","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O","inchiKey":"IIDJRNMFWXDHID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RISEDRONIC ACID","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Actonel","M05BA07","NE-58095","Ridron","Risedronate","Risedronic acid"],"crossReferences":{"DailyMed":["risedronate%20sodium"],"PubChem":["29216086"],"Wikipedia":["Risedronic_acid"],"drugbank":["DB00884"],"chEBI":["8869"]},"childChemblIds":["CHEMBL4303174","CHEMBL3560765","CHEMBL1654"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0004261","MONDO_0021117","EFO_1001919","MONDO_0007254","Orphanet_249","EFO_0004260","HP_0003418","Orphanet_666","EFO_0003882","MONDO_0008315","EFO_1001152","MONDO_0021165","EFO_0000565","HP_0000938","EFO_0003854","EFO_0003957","EFO_0000196","EFO_0000574","EFO_0004215","MONDO_0002635","EFO_0003922"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 4 approved and 16 investigational indications."}
